Skip to main content
. 2014 Apr 15;4(4):e383. doi: 10.1038/tp.2014.14

Table 4. Association between vitamin D levels, severity of depressive symptoms and use of antidepressants in one, fully adjusted linear regression model (n=355).

Characteristic Calcidiol (25-(OH)D3)
Calcitriol (1,25-(OH)2D3)
  B (s.e.) β P B (s.e.) β P
Model 1 (n=355)
 Use of a SSRI (1=yes) −1.73 (2.93) −0.03 0.553 −7.84 (5.78) −0.07 0.176
 Use of a TCA (1=yes) −3.65 (3.37) −0.07 0.280 −31.78 (6.64) −0.27 <0.001
 Use of other antidepressants (1=yes) −3.84 (2.89) −0.08 0.184 −2.23 (5.69) −0.02 0.695
             
Model 2 (n=355)
 Use of a SSRI (1=yes) −1.01 (2.95) −0.02 0.732 −7.03 (5.82) −0.07 0.228
 Use of a TCA (1=yes) −2.08 (3.49) −0.04 0.553 −28.13 (6.89) −0.24 <0.001
 Use of other antidepressants (1=yes) −3.69 (2.88) −0.07 0.201 −1.79 (5.68) −0.02 0.753

Abbreviations: eGFR, estimated glomerular filtration rate; MMSE, Mini Mental State Examination; SSRI, selective serotonin reuptake inhibitor; TCA, tricyclic antidepressants.

Model 1: Adjusted for age, sex, level of education, smoking status (yes/no), alcohol use (no, moderate, severe), physical activity (low, medium, large), waist circumference, renal function (eGFR), chronic comorbid diseases and global cognitive functioning (MMSE).

Model 2: Similar to model 1, but additionally adjusted for depressive symptom severity and inversus outpatient status.